Thrivent Financial for Lutherans cut its position in shares of Haleon plc (NYSE:HLN – Free Report) by 12.2% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 48,795 shares of the company’s stock after selling 6,798 shares during the quarter. Thrivent Financial for Lutherans’ holdings in Haleon were worth $466,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Addison Advisors LLC grew its stake in shares of Haleon by 28.7% in the fourth quarter. Addison Advisors LLC now owns 4,954 shares of the company’s stock valued at $47,000 after buying an additional 1,106 shares in the last quarter. Synovus Financial Corp raised its stake in Haleon by 0.8% during the third quarter. Synovus Financial Corp now owns 148,834 shares of the company’s stock valued at $1,575,000 after buying an additional 1,216 shares in the last quarter. Greenleaf Trust lifted its stake in Haleon by 8.4% during the fourth quarter. Greenleaf Trust now owns 17,225 shares of the company’s stock worth $164,000 after purchasing an additional 1,333 shares during the last quarter. Baron Wealth Management LLC lifted its position in shares of Haleon by 4.3% in the 4th quarter. Baron Wealth Management LLC now owns 33,632 shares of the company’s stock worth $321,000 after buying an additional 1,381 shares during the last quarter. Finally, Peapack Gladstone Financial Corp grew its position in shares of Haleon by 3.2% during the 3rd quarter. Peapack Gladstone Financial Corp now owns 44,844 shares of the company’s stock valued at $474,000 after buying an additional 1,390 shares during the last quarter. Institutional investors and hedge funds own 6.67% of the company’s stock.
Analyst Ratings Changes
A number of equities analysts have issued reports on the stock. Sanford C. Bernstein cut shares of Haleon from an “outperform” rating to a “market perform” rating in a report on Wednesday, January 8th. Morgan Stanley lowered Haleon from an “overweight” rating to an “equal weight” rating in a research report on Friday, January 10th. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating on shares of Haleon in a research report on Monday, March 3rd. HSBC reissued a “hold” rating on shares of Haleon in a report on Wednesday, March 5th. Finally, Hsbc Global Res cut shares of Haleon from a “strong-buy” rating to a “hold” rating in a report on Wednesday, March 5th. Six equities research analysts have rated the stock with a hold rating, one has issued a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $10.95.
Haleon Stock Performance
Shares of HLN stock opened at $10.45 on Friday. The business has a 50 day simple moving average of $10.02 and a 200 day simple moving average of $9.87. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.84 and a quick ratio of 0.58. The firm has a market capitalization of $47.29 billion, a price-to-earnings ratio of 30.72, a price-to-earnings-growth ratio of 2.82 and a beta of 0.25. Haleon plc has a 12-month low of $7.99 and a 12-month high of $10.80.
Haleon (NYSE:HLN – Get Free Report) last released its quarterly earnings results on Thursday, February 27th. The company reported $0.05 earnings per share (EPS) for the quarter. The company had revenue of $3.54 billion during the quarter, compared to analysts’ expectations of $3.38 billion. Haleon had a return on equity of 14.76% and a net margin of 10.85%. On average, equities research analysts anticipate that Haleon plc will post 0.43 EPS for the current year.
Haleon Increases Dividend
The business also recently announced a — dividend, which will be paid on Thursday, June 5th. Investors of record on Friday, April 25th will be given a $0.1166 dividend. This represents a yield of 1.6%. The ex-dividend date of this dividend is Friday, April 25th. This is a positive change from Haleon’s previous — dividend of $0.05. Haleon’s dividend payout ratio is currently 58.97%.
About Haleon
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.
Featured Stories
- Five stocks we like better than Haleon
- EV Stocks and How to Profit from Them
- Shares of RH Down Nearly 40%: Where Investors Can Turn To Now
- How to Plot Fibonacci Price Inflection Levels
- Tariffs, Spin-Out, and R2 Updates Are Positive Signs for Rivian
- 3 Best Fintech Stocks for a Portfolio Boost
- Cathie Wood Loads Up on Baidu—Is It the Right Time to Buy?
Want to see what other hedge funds are holding HLN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Haleon plc (NYSE:HLN – Free Report).
Receive News & Ratings for Haleon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Haleon and related companies with MarketBeat.com's FREE daily email newsletter.